JNJ vs UNH
Johnson & Johnson vs UnitedHealth Group Incorporated · Updated Nov 9, 2026
JNJ — 14 winsUNH — 9 wins
Price Performance
JNJ +49.78%UNH +23.48%
Performance
| JNJ | UNH | |
|---|---|---|
| 1 Month | +7.22% | +6.10% |
| 3 Months | +5.04% | -3.71% |
| 6 Months | +24.26% | +3.58% |
| YTD | +32.89% | +19.23% |
| 1 Year | +47.85% | +18.97% |
| 3 Year | +67.59% | -21.95% |
| 5 Year | +68.58% | +21.24% |
Yearly Returns
| YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | +36.1% | +43.7% | -9.6% | -12.0% | +3.0% | +9.3% | +7.8% | +14.2% | -7.3% | +20.6% | +14.7% | -1.7% |
| UNH | +18.0% | -35.6% | -6.2% | +1.5% | +5.5% | +43.7% | +19.9% | +20.7% | +12.6% | +36.5% | +37.4% | +16.7% |
Valuation
| JNJ | UNH | |
|---|---|---|
| P/E Ratio | 31.79 | 29.72 |
| Forward P/E | 11.17 | 9.99 |
| PEG Ratio | 2.75 | 2.08 |
| P/S Ratio | 6.65 | 0.81 |
| P/B Ratio | 7.89 | 3.49 |
| EV/EBITDA | 22.48 | 14.37 |
Financials
| JNJ | UNH | |
|---|---|---|
| EPS (TTM) | $8.65 | $13.24 |
| Gross Margin | +71.49% | +22.74% |
| Operating Margin | +26.58% | +8.05% |
| Net Margin | +21.76% | +5.62% |
| ROE | +25.92% | +11.59% |
| ROA | +10.47% | +3.85% |
| Debt/Equity | 0.22 | 0.75 |
Growth
| JNJ | UNH | |
|---|---|---|
| Revenue Growth YoY | +9.91% | +1.96% |
| Revenue Growth QoQ | -2.04% | -1.32% |
| EPS Growth YoY | -52.86% | +0.73% |
| EPS Growth QoQ | +1.90% | +62627.30% |
Technical
| JNJ | UNH | |
|---|---|---|
| RSI (14) | 55.78 | 47.35 |
| % From 20-Day SMA | +3.90% | -2.78% |
| % From 50-Day SMA | +3.47% | +0.75% |
| % From 200-Day SMA | +10.74% | +7.95% |
| % From 52-Week High | -2.48% | -14.74% |
| % From 52-Week Low | +48.56% | +53.76% |
Analyst Ratings
JNJ
Buy(25 analysts)
Strong SellHoldStrong Buy
Price Target
$285.31
+3.75% upside
UNH
Buy(39 analysts)
Strong SellHoldStrong Buy
Price Target
$478.68
+21.62% upside
Overview
| JNJ | UNH | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Medical - Healthcare Plans |
| Exchange | NYSE | NYSE |
| Market Cap | $640.75B | $363.02B |
| Shares Outstanding | 2.41B | 897.6M |
| Avg Volume (10D) | 7.60M | 5.23M |
| Dividend Yield | 1.98% | 2.24% |
Frequently Asked Questions
Is JNJ or UNH a better buy right now?
Based on 23 comparable metrics, JNJ leads in 14 categories while UNH leads in 9. JNJ has a consensus analyst rating with 25 analysts covering the stock. Neither stock should be purchased based on a single comparison — consider your investment goals and risk tolerance.
Which stock has better performance, JNJ or UNH?
Over the past year, JNJ returned +47.85% compared to UNH's +18.97%. In the short term (1 month), JNJ returned +7.22% vs UNH's +6.10%.
Is JNJ or UNH more expensive?
JNJ trades at a P/E of 31.79 compared to UNH's 29.72. On a price-to-sales basis, JNJ trades at 6.65x vs UNH's 0.81x. Forward P/E: JNJ at 11.17 vs UNH at 9.99.
Which stock has higher growth, JNJ or UNH?
JNJ's revenue grew +9.91% year-over-year compared to UNH's +1.96%. EPS growth: JNJ at -52.86% vs UNH at +0.73%.
Do JNJ and UNH pay dividends?
JNJ pays a dividend with a yield of 1.98%. UNH pays a dividend with a yield of 2.24%.
Which stock do analysts prefer, JNJ or UNH?
JNJ has 25 analysts with a target price of $285.31 (+3.75% upside). UNH has 39 analysts with a target of $478.68 (+21.62% upside).
Data updated daily. All comparisons based on latest available market data. Not investment advice.